HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

NPA analysis finds over 6 million hours spent in A&E on cases treatable by community pharmacies

A new report by the National Pharmacy Association reveals that patients spent over 6 million hours in A&E last year for minor health issues that could have been managed by community pharmacies, highlighting an opportunity to ease pressure on emergency services.

Medical cannabis-based treatments: Research, production & distribution

Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments

The UK’s doomed Medical Cannabis (Access) Bill

Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP, explore the UK’s doomed Medical Cannabis (Access) Bill

Antimicrobial resistance now kills more people than HIV or malaria

According to a new study in The Lancet, antimicrobial resistance is now a leading cause of death worldwide, higher than HIV/AIDS or malaria.

New Pfizer Covid-19 pill seeking emergency use authorization from FDA

Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™

How to compete with COVID-19 with a computer?

Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Pfizer COVID-19 pill 89% effective against death

Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

TIGRR: Is it a wonderful thing for the UK’s Cannabis Industry?

BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).

The risks of anabolic steroids

Dr Deborah Lee, Dr Fox Online Pharmacy, explores the risks associated with anabolic steroids and how to get help if you have an addiction.

Are you eligible for the COVID-19 booster jab?

Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.

New EU rules on veterinary medicines to support responsible use of antibiotics

Roxane Feller, AnimalhealthEurope Secretary-General, tells us all about the new EU rules on veterinary medicines to support more responsible use of antibiotics.

Mirtazapine not effective in treating dementia patients

Mirtazapine, an antidepressant drug given to dementia patients, has been found to be no more effective than a placebo and increases mortality.

Risk of pregnancy loss not associated with COVID-19 vaccines

According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.

FDA approves Pfizer booster vaccine for over 65s

The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.

Changing the treatment paradigm in Inflammatory Bowel Diseases

Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.

The impact and importance of psychedelic medicine

Here, we discover the impact and importance of psychedelic medicine through the eyes of Amanda Feilding, Director of The Beckley Foundation.

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders